Amicus Therapeutics Inc (FOLD)
Stock-Based Compensation
$26.59M
Quarterly · Period ending: · USD
FOLD Stock-Based Compensation
Latest reported$26.59Mperiod ending
Latest reported$26.59Mperiod ending
FOLD Quarterly Stock-Based Comp ($0.00 → $26.59M)
Quarterly stock-based compensation
High-resolution chart · PNG
FOLD stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 26,590,000 | |
| 18,089,000 | |
| 17,559,000 | |
| 25,172,000 | |
| 19,217,000 | |
| 18,688,000 | |
| 16,197,000 | |
| 30,803,000 | |
| 0 | |
| 16,511,000 | |
| 16,577,000 | |
| 34,894,000 | |
| 18,626,000 | |
| 14,772,000 | |
| 12,463,000 | |
| 30,651,000 | |
| 13,907,000 | |
| 11,841,000 | |
| 11,736,000 | |
| 20,354,000 | |
| 0 | |
| 0 | |
| 8,408,000 | |
| 12,596,000 | |
| 12,908,000 | |
| 8,843,000 | |
| 9,935,000 | |
| 12,744,000 | |
| 8,387,000 | |
| 7,054,000 | |
| 6,341,000 | |
| 7,478,000 | |
| 6,034,000 | |
| 5,500,000 | |
| 5,537,000 | |
| 6,030,000 | |
| 4,417,000 | |
| 4,339,000 | |
| 4,465,000 | |
| 4,283,000 | |
| 3,043,000 | |
| 2,738,000 | |
| 2,231,000 | |
| 1,960,000 | |
| 1,610,000 | |
| 1,650,000 | |
| 1,488,000 | |
| 1,260,000 | |
| 1,503,000 | |
| 1,517,000 | |
| 1,583,000 | |
| 1,574,000 | |
| 1,448,000 | |
| 1,598,000 | |
| 1,757,000 | |
| 1,388,000 | |
| 1,436,000 | |
| 1,941,000 | |
| 3,884,000 | |
| 1,418,000 | |
| 1,484,000 | |
| 1,483,000 | |
| 1,503,000 | |
| 1,716,000 | |
| 1,748,000 | |
| 1,970,000 | |
| 2,097,000 | |
| 1,972,000 | |
| 6,446,000 | |
| 0 | |
| 0 | |
| 705,000 | |
| 2,816,000 | |
| 0 | |
| 0 | |
| 0 |